Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Consolidation durvalumab poised to become ‘new standard’ for limited-stage SCLC
Consolidation treatment with the PD-L1 antibody durvalumab following concurrent chemoradiotherapy significantly prolonged overall (OS) and progression-free survival (PFS) in patients with limited-stage small-cell lung cancer (SCLC), as shown in the interim analysis of the phase III ADRIATIC trial.

Nivolumab plus chemo offers prolonged survival in resectable NSCLC
Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate 816 study.

Fatigue, pain weigh down people with fibromyalgia
Several symptoms of individuals with fibromyalgia (FM), including fatigue and sleep disturbance, have significant impacts on their daily life, and the prevalence of such symptoms may vary depending on demographic categories and disability status, according to a study.





